IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Repros Therapeutics Inc

CUSIP: 76028H209 | 203 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

IFP Advisors, Inc12
0.0% of portfolio›$0
StyleTurnoverLocationFiled
IFP Advisors, Inc
12$00.0%GrowthLowTampa, FL2019-06-03